<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36253560</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-7254</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta pharmacologica Sinica</Title><ISOAbbreviation>Acta Pharmacol Sin</ISOAbbreviation></Journal><ArticleTitle>Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.</ArticleTitle><Pagination><StartPage>695</StartPage><EndPage>709</EndPage><MedlinePgn>695-709</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41401-022-00998-0</ELocationID><Abstract><AbstractText>The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute manifestations of COVID-19 (long COVID-19) is understudied. Endothelial cells are sentinels lining the innermost layer of blood vessel that gatekeep micro- and macro-vascular health by sensing pathogen/danger signals and secreting vasoactive molecules. SARS-CoV-2 infection primarily affects the pulmonary system, but accumulating evidence suggests that it also affects the pan-vasculature in the extrapulmonary systems by directly (via virus infection) or indirectly (via cytokine storm), causing endothelial dysfunction (endotheliitis, endothelialitis and endotheliopathy) and multi-organ injury. Mounting evidence suggests that SARS-CoV-2 infection leads to multiple instances of endothelial dysfunction, including reduced nitric oxide (NO) bioavailability, oxidative stress, endothelial injury, glycocalyx/barrier disruption, hyperpermeability, inflammation/leukocyte adhesion, senescence, endothelial-to-mesenchymal transition (EndoMT), hypercoagulability, thrombosis and many others. Thus, COVID-19 is deemed as a (micro)vascular and endothelial disease. Of translational relevance, several candidate drugs which are endothelial protective have been shown to improve clinical manifestations of COVID-19 patients. The purpose of this review is to provide a latest summary of biomarkers associated with endothelial cell activation in COVID-19 and offer mechanistic insights into the molecular basis of endothelial activation/dysfunction in macro- and micro-vasculature of COVID-19 patients. We envisage further development of cellular models and suitable animal models mimicking endothelial dysfunction aspect of COVID-19 being able to accelerate the discovery of new drugs targeting endothelial dysfunction in pan-vasculature from COVID-19 patients.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Suo-Wen</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-5488-5217</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, 230001, China. sxu1984@ustc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilyas</LastName><ForeName>Iqra</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, 230001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Jian-Ping</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-7889-1697</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, 230001, China. wengjp@ustc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Acta Pharmacol Sin</MedlineTA><NlmUniqueID>100956087</NlmUniqueID><ISSNLinking>1671-4083</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">endothelialitis</Keyword><Keyword MajorTopicYN="N">endotheliitis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36253560</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pii">10.1038/s41401-022-00998-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10:40. doi: 10.1186/s13578-020-00404-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00404-4</ArticleId><ArticleId IdType="pmc">PMC7074995</ArticleId><ArticleId IdType="pubmed">32190290</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, et al. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713. doi: 10.1155/2021/8671713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8671713</ArticleId><ArticleId IdType="pmc">PMC8397545</ArticleId><ArticleId IdType="pubmed">34457119</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnaubelt S, Oppenauer J, Tihanyi D, Mueller M, Maldonado-Gonzalez E, Zejnilovic S, et al. Arterial stiffness in acute COVID-19 and potential associations with clinical outcome. J Intern Med. 2021;290:437&#x2013;43. doi: 10.1111/joim.13275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13275</ArticleId><ArticleId IdType="pmc">PMC8013324</ArticleId><ArticleId IdType="pubmed">33651387</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038&#x2013;44. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezoh G, Crowther NJ. Endothelial dysfunction as a primary consequence of SARS-CoV-2 Infection. Adv Exp Med Biol. 2021;1321:33&#x2013;43. doi: 10.1007/978-3-030-59261-5_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-59261-5_3</ArticleId><ArticleId IdType="pubmed">33656711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D&#x2019;Anna SE, Bachetti T, et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10:812. doi: 10.3390/biomedicines10040812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rooij L, Becker LM, Carmeliet P. A role for the vascular endothelium in post-acute COVID-19? Circulation. 2022;145:1503&#x2013;5. doi: 10.1161/CIRCULATIONAHA.122.059231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059231</ArticleId><ArticleId IdType="pubmed">35576316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladka MM, Maack C. The endothelium as Achilles&#x2019; heel in COVID-19 patients. Cardiovasc Res. 2020;116:e195&#x2013;e7. doi: 10.1093/cvr/cvaa327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa327</ArticleId><ArticleId IdType="pmc">PMC7717148</ArticleId><ArticleId IdType="pubmed">33167001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142:1609&#x2013;11. doi: 10.1161/CIRCULATIONAHA.120.050354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050354</ArticleId><ArticleId IdType="pmc">PMC7580651</ArticleId><ArticleId IdType="pubmed">32877231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol. 2021;164:69&#x2013;82. doi: 10.1016/j.yjmcc.2021.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. 2022;140:222&#x2013;35. doi: 10.1182/blood.2021012250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Basta G. Direct or indirect endothelial damage? An unresolved question. EBioMedicine. 2021;64:103215. doi: 10.1016/j.ebiom.2021.103215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103215</ArticleId><ArticleId IdType="pmc">PMC7823198</ArticleId><ArticleId IdType="pubmed">33493794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-&#x3b1;/IFN-&#x3b3; synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell. 2022;21:e13646. doi: 10.1111/acel.13646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13646</ArticleId><ArticleId IdType="pmc">PMC9197409</ArticleId><ArticleId IdType="pubmed">35645319</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;gele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58&#x2013;62. doi: 10.1016/j.atherosclerosis.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7554490</ArticleId><ArticleId IdType="pubmed">33161318</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924&#x2013;67. doi: 10.1124/pharmrev.120.000096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pharmrev.120.000096</ArticleId><ArticleId IdType="pubmed">34088867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;32. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Kacmarek RM. The American-European Consensus Conference definition of the acute respiratory distress syndrome is dead, long live positive end-expiratory pressure! Med Intensiv. 2012;36:571&#x2013;5. doi: 10.1016/j.medin.2012.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2012.08.010</ArticleId><ArticleId IdType="pubmed">23017630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, Khurram Syed S, Fatima M, Shaukat S, Saadullah M, Alqahtani AM, et al. Acute respiratory distress syndrome and COVID-19: a literature review. J Inflamm Res. 2021;14:7225&#x2013;42. doi: 10.2147/JIR.S334043.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S334043</ArticleId><ArticleId IdType="pmc">PMC8710428</ArticleId><ArticleId IdType="pubmed">34992415</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR. Insights into endotheliopathy in COVID-19. Am J Respir Crit Care Med. 2022. 10.1164/rccm.202207-1258ED.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9801991</ArticleId><ArticleId IdType="pubmed">35819867</ArticleId></ArticleIdList></Reference><Reference><Citation>Six I, Guillaume N, Jacob V, Mentaverri R, Kamel S, Boullier A, et al. The endothelium and COVID-19: an increasingly clear link brief title: endotheliopathy in COVID-19. Int J Mol Sci. 2022;23:6196. doi: 10.3390/ijms23116196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23116196</ArticleId><ArticleId IdType="pmc">PMC9181280</ArticleId><ArticleId IdType="pubmed">35682871</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci. 2021;7:1156&#x2013;65. doi: 10.1021/acscentsci.0c01537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01537</ArticleId><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in &#x39a;18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477&#x2013;l84. doi: 10.1152/ajplung.00223.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00223.2021</ArticleId><ArticleId IdType="pmc">PMC8384477</ArticleId><ArticleId IdType="pubmed">34156871</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre J, Rodriguez L, Matthay ZA, Lloyd E, Fields AT, Bainton RJ, et al. COVID-19-Associated lung microvascular endotheliopathy: a &#x201c;from the bench&#x201d; perspective. Am J Respir Crit Care Med. 2022. 10.1164/rccm.202107-1774OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9801996</ArticleId><ArticleId IdType="pubmed">35649173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashour L. Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis. Tissue Barriers. 2022; 2090792. 10.1080/21688370.2022.2090792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10161962</ArticleId><ArticleId IdType="pubmed">35726726</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial damage in acute respiratory distress syndrome. Int J Mol Sci. 2020;21:8793. doi: 10.3390/ijms21228793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228793</ArticleId><ArticleId IdType="pmc">PMC7699909</ArticleId><ArticleId IdType="pubmed">33233715</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang HG. Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection. Front Med. 2020;7:629413. doi: 10.3389/fmed.2020.629413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.629413</ArticleId><ArticleId IdType="pmc">PMC7855580</ArticleId><ArticleId IdType="pubmed">33553222</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666&#x2013;87. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116:1097&#x2013;100. doi: 10.1093/cvr/cvaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet (Lond, Engl) 2021;398:599&#x2013;607. doi: 10.1016/S0140-6736(21)00896-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fardman A, Zahger D, Orvin K, Oren D, Kofman N, Mohsen J, et al. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry. PLoS One. 2021;16:e0253524. doi: 10.1371/journal.pone.0253524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253524</ArticleId><ArticleId IdType="pmc">PMC8213163</ArticleId><ArticleId IdType="pubmed">34143840</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano O, Cosentino N, Campodonico J, Bartorelli AL, Marenzi G. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med. 2021;8:648290. doi: 10.3389/fcvm.2021.648290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.648290</ArticleId><ArticleId IdType="pmc">PMC8733166</ArticleId><ArticleId IdType="pubmed">35004867</ArticleId></ArticleIdList></Reference><Reference><Citation>Aye YN, Mai AS, Zhang A, Lim OZH, Lin N, Ng CH, et al. Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM. 2021. 10.1093/qjmed/hcab252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522388</ArticleId><ArticleId IdType="pubmed">34586408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Larabee JL, Gao L, Shi H, Shao B, Hoover CM, et al. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI insight. 2021;6:e148999. doi: 10.1172/jci.insight.148999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148999</ArticleId><ArticleId IdType="pmc">PMC8410055</ArticleId><ArticleId IdType="pubmed">34291736</ArticleId></ArticleIdList></Reference><Reference><Citation>Saviano A, Baumert TF. Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury. J Hepatol. 2021;75:503&#x2013;5. doi: 10.1016/j.jhep.2021.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.07.008</ArticleId><ArticleId IdType="pmc">PMC8280619</ArticleId><ArticleId IdType="pubmed">34274367</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, et al. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol. 2021;75:647&#x2013;58. doi: 10.1016/j.jhep.2021.04.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.04.050</ArticleId><ArticleId IdType="pmc">PMC8285256</ArticleId><ArticleId IdType="pubmed">33991637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231&#x2013;40. doi: 10.1016/j.jhep.2020.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.06.006</ArticleId><ArticleId IdType="pmc">PMC7295524</ArticleId><ArticleId IdType="pubmed">32553666</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander MP, Mangalaparthi KK, Madugundu AK, Moyer AM, Adam BA, Mengel M, et al. Acute kidney injury in severe COVID-19 has similarities to sepsis-associated kidney injury: a multi-omics study. Mayo Clin Proc. 2021;96:2561&#x2013;75. doi: 10.1016/j.mayocp.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8279954</ArticleId><ArticleId IdType="pubmed">34425963</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, de Oliveira MHS, Cheruiyot I, Benoit JL, Cooper DS, Lippi G, et al. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19) Angiogenesis. 2021;24:403&#x2013;6. doi: 10.1007/s10456-021-09782-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09782-w</ArticleId><ArticleId IdType="pmc">PMC7985913</ArticleId><ArticleId IdType="pubmed">33755876</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni TE, Medici V, Moretti M, Vison&#xe0; SD, Cirrincione A, Carlos AF, et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol (Zur, Switz) 2021;31:e12997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaundal RK, Kalvala AK, Kumar A. Neurological implications of COVID-19: role of redox imbalance and mitochondrial dysfunction. Mol Neurobiol. 2021;58:4575&#x2013;87. doi: 10.1007/s12035-021-02412-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02412-y</ArticleId><ArticleId IdType="pmc">PMC8190166</ArticleId><ArticleId IdType="pubmed">34110602</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta P, Maniscalco M, Papa A, Lanzillo A, Trojano L, Ambrosino P. Cognitive impairment and endothelial dysfunction in convalescent COVID-19 patients undergoing rehabilitation. Eur J Clin Invest. 2022;52:e13726. doi: 10.1111/eci.13726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13726</ArticleId><ArticleId IdType="pubmed">34921559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilonzo N, Judelson D, Al-Jundi W, Etkin Y, O&#x2019;Banion LA, Rivera A, et al. A review of acute limb ischemia in COVID-positive patients. Semin Vasc Surg. 2021;34:8&#x2013;12. doi: 10.1053/j.semvascsurg.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semvascsurg.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8167656</ArticleId><ArticleId IdType="pubmed">34144749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Jannini EA. COVID-19 and erectile dysfunction: endothelial dysfunction and beyond. world J men&#x2019;s health. 2021;39:820&#x2013;1. doi: 10.5534/wjmh.210081.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210081</ArticleId><ArticleId IdType="pmc">PMC8443984</ArticleId><ArticleId IdType="pubmed">34184433</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, et al. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin. J Virol. 2021;95:e0139621. doi: 10.1128/JVI.01396-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01396-21</ArticleId><ArticleId IdType="pmc">PMC8577385</ArticleId><ArticleId IdType="pubmed">34549987</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa LC, Gon&#xe7;alves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vasc Pharmacol. 2021;137:106829. doi: 10.1016/j.vph.2021.106829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106829</ArticleId><ArticleId IdType="pmc">PMC7834309</ArticleId><ArticleId IdType="pubmed">33422689</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63:103182. doi: 10.1016/j.ebiom.2020.103182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Klouda T, Hao Y, Kim H, Kim J, Olejnik J, Hume AJ, et al. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2. Angiogenesis. 2022;25:225&#x2013;40. doi: 10.1007/s10456-021-09823-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09823-4</ArticleId><ArticleId IdType="pmc">PMC8554520</ArticleId><ArticleId IdType="pubmed">34714440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Sun S, Li J, Fan Y, Qu J, Sun L, et al. Single-cell transcriptomic atlas of primate cardiopulmonary aging. Cell Res. 2021;31:415&#x2013;32. doi: 10.1038/s41422-020-00412-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00412-6</ArticleId><ArticleId IdType="pmc">PMC7483052</ArticleId><ArticleId IdType="pubmed">32913304</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, et al. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunol. 2021;10:e1350. doi: 10.1002/cti2.1350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1350</ArticleId><ArticleId IdType="pmc">PMC8542944</ArticleId><ArticleId IdType="pubmed">34721846</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Rahimi N. COVID-19, Renin-Angiotensin system and endothelial dysfunction. Cells. 2020;9:1652. doi: 10.3390/cells9071652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071652</ArticleId><ArticleId IdType="pmc">PMC7407648</ArticleId><ArticleId IdType="pubmed">32660065</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet (Lond, Engl) 2020;395:1417&#x2013;8. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Br&#xe4;sen JH, Hoeper MM, David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020;46:2081&#x2013;2. doi: 10.1007/s00134-020-06237-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06237-6</ArticleId><ArticleId IdType="pmc">PMC7483488</ArticleId><ArticleId IdType="pubmed">32915253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall&#x2019;Asta V. Endothelial cell activation by SARS-CoV-2 Spike S1 protein: a crosstalk between endothelium and innate immune cells. Biomedicines. 2021;9:1220. doi: 10.3390/biomedicines9091220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091220</ArticleId><ArticleId IdType="pmc">PMC8470710</ArticleId><ArticleId IdType="pubmed">34572407</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Li J, Wang PH, Yang N, Huang J, Ou J, et al. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochimica et Biophysica Acta Mol Basis Dis. 2021;1867:166260. doi: 10.1016/j.bbadis.2021.166260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166260</ArticleId><ArticleId IdType="pmc">PMC8390448</ArticleId><ArticleId IdType="pubmed">34461258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jover E, Matilla L, Garaikoetxea M, Fern&#xe1;ndez-Celis A, Muntendam P, Jaisser F, et al. Beneficial effects of mineralocorticoid receptor pathway blockade against endothelial inflammation induced by SARS-CoV-2 spike protein. Biomedicines. 2021;9:639. doi: 10.3390/biomedicines9060639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9060639</ArticleId><ArticleId IdType="pmc">PMC8228852</ArticleId><ArticleId IdType="pubmed">34204890</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S, Kenchappa DB, Leo MD. SARS-CoV-2 spike protein induces degradation of junctional proteins that maintain endothelial barrier integrity. Front Cardiovasc Med. 2021;8:687783. doi: 10.3389/fcvm.2021.687783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.687783</ArticleId><ArticleId IdType="pmc">PMC8225996</ArticleId><ArticleId IdType="pubmed">34179146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323&#x2013;6. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering SB, de Sousa FTG, Tjang LV, Pahmeier F, Ruan R, Blanc SF, et al. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-&#x3b2; signaling. bioRxiv: the preprint server for biology 2021. 10.1101/2021.12.10.472112.</Citation></Reference><Reference><Citation>Frisoni P, Neri M, D&#x2019;Errico S, Alfieri L, Bonuccelli D, Cingolani M, et al. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1&#x3b2;, IL-6, IL-15 and TNF-&#x3b1;. Forensic Sci Med Pathol. 2021: 1-15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406387</ArticleId><ArticleId IdType="pubmed">34463916</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Jiang L, Li X, Lin F, Wang Y, Li B, et al. Clinical and pathological investigation of patients with severe COVID-19. JCI insight. 2020;5:e138070. doi: 10.1172/jci.insight.138070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138070</ArticleId><ArticleId IdType="pmc">PMC7406259</ArticleId><ArticleId IdType="pubmed">32427582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255&#x2013;73. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S, Mendes MC, Camargo Martins AP, Borges NH, Godoy TM, Miggiolaro A, et al. Endothelial dysfunction and thrombosis in patients with COVID-19-brief report. Arteriosclerosis Thrombosis Vasc Biol. 2020;40:2404&#x2013;7. doi: 10.1161/ATVBAHA.120.314860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314860</ArticleId><ArticleId IdType="pmc">PMC7505138</ArticleId><ArticleId IdType="pubmed">32762443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sur S, Steele R, Isbell TS, Ray R, Ray RB. Circulatory exosomes from COVID-19 patients trigger NLRP3 inflammasome in endothelial cells. mBio. 2022: e0095122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239151</ArticleId><ArticleId IdType="pubmed">35587188</ArticleId></ArticleIdList></Reference><Reference><Citation>Torices S, Motta C, da Rosa B, Marcos A, Alvarez-Rosa L, Siqueira M, et al. SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-&#x3ba;B non-canonical pathway and mitochondrial remodeling. Res Square. 2022. 10.21203/rs.3.rs-1762855/v1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Potje SR, Costa TJ, Fraga-Silva TFC, Martins RB, Benatti MN, Almado CEL, et al. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients. Life Sci. 2021;276:119376. doi: 10.1016/j.lfs.2021.119376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119376</ArticleId><ArticleId IdType="pmc">PMC7997864</ArticleId><ArticleId IdType="pubmed">33781826</ArticleId></ArticleIdList></Reference><Reference><Citation>du Preez HN, Aldous C, Hayden MR, Kruger HG, Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J. 2022;36:e22052. doi: 10.1096/fj.202101100RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202101100RR</ArticleId><ArticleId IdType="pubmed">34862979</ArticleId></ArticleIdList></Reference><Reference><Citation>Targosz-Korecka M, Kubisiak A, Kloska D, Kopacz A, Grochot-Przeczek A, Szymonski M. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors. Sci Rep. 2021;11:12157. doi: 10.1038/s41598-021-91231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91231-1</ArticleId><ArticleId IdType="pmc">PMC8190434</ArticleId><ArticleId IdType="pubmed">34108510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Gronski PA, Kiyan Y, Seeliger B, Bertram A, Pape T, et al. Injury to the endothelial glycocalyx in critically Ill patients with COVID-19. Am J Respiratory Crit Care Med. 2020;202:1178&#x2013;81. doi: 10.1164/rccm.202007-2676LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2676LE</ArticleId><ArticleId IdType="pmc">PMC7560808</ArticleId><ArticleId IdType="pubmed">32833500</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19. Int J Mol Sci. 2020;21:9712. doi: 10.3390/ijms21249712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249712</ArticleId><ArticleId IdType="pmc">PMC7766512</ArticleId><ArticleId IdType="pubmed">33352699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, et al. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses. 2021;13:23424. doi: 10.3390/v13112324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Eapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A, et al. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020;56:2003167. doi: 10.1183/13993003.03167-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03167-2020</ArticleId><ArticleId IdType="pmc">PMC7453738</ArticleId><ArticleId IdType="pubmed">32859681</ArticleId></ArticleIdList></Reference><Reference><Citation>Falleni M, Tosi D, Savi F, Chiumello D, Bulfamante G. Endothelial-mesenchymal transition in COVID-19 lung lesions. Pathol Res Pract. 2021;221:153419. doi: 10.1016/j.prp.2021.153419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2021.153419</ArticleId><ArticleId IdType="pmc">PMC7997691</ArticleId><ArticleId IdType="pubmed">33857718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, et al. Effect of SARS-CoV-2 proteins on vascular permeability. eLife. 2021;10:e69314. doi: 10.7554/eLife.69314.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69314</ArticleId><ArticleId IdType="pmc">PMC8545399</ArticleId><ArticleId IdType="pubmed">34694226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RC, Huang K, Zhang HP, Li L, Zhang YF, Tan C, et al. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Jiang Y, Xia D, Xiong Y, Zheng Q, Chen F, et al. Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients. J Infect Dis. 2020;222:894&#x2013;8. doi: 10.1093/infdis/jiaa349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa349</ArticleId><ArticleId IdType="pmc">PMC7337874</ArticleId><ArticleId IdType="pubmed">32582936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Zuo Y, Yalavarthi S, Hunker KL, Knight JS, Kanthi Y, et al. SARS-CoV-2 spike protein S1-mediated endothelial injury and pro-inflammatory state is amplified by dihydrotestosterone and prevented by mineralocorticoid antagonism. Viruses. 2021;13:2209. doi: 10.3390/v13112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112209</ArticleId><ArticleId IdType="pmc">PMC8617813</ArticleId><ArticleId IdType="pubmed">34835015</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, et al. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076&#x2013;91. doi: 10.7150/thno.61810.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61810</ArticleId><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Won T, Wood MK, Hughes DM, Talor MV, Ma Z, Schneider J, et al. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine. 2022;75:103812. doi: 10.1016/j.ebiom.2022.103812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103812</ArticleId><ArticleId IdType="pmc">PMC8756077</ArticleId><ArticleId IdType="pubmed">35033854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebihara T, Matsumoto H, Matsubara T, Togami Y, Nakao S, Matsuura H, et al. Resistin associated with cytokines and endothelial cell adhesion molecules is related to worse outcome in COVID-19. Front Immunol. 2022;13:830061. doi: 10.3389/fimmu.2022.830061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.830061</ArticleId><ArticleId IdType="pmc">PMC9243394</ArticleId><ArticleId IdType="pubmed">35784283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Lee TH, Huang RT, D Guzy R, Schoettler N, Adegunsoye A, et al. SARS-CoV-2 infection is associated with reduced kr&#xfc;ppel-like factor 2 in human lung autopsy. Am J Respiratory Cell Mol Biol. 2021;65:222&#x2013;6. doi: 10.1165/rcmb.2020-0564LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0564LE</ArticleId><ArticleId IdType="pmc">PMC8399572</ArticleId><ArticleId IdType="pubmed">33971111</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, et al. SARS-CoV-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells. Microorganisms. 2021;9:1438. doi: 10.3390/microorganisms9071438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071438</ArticleId><ArticleId IdType="pmc">PMC8305478</ArticleId><ArticleId IdType="pubmed">34361874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;8. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ. 2020;10:2045894020966547. doi: 10.1177/2045894020966547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045894020966547</ArticleId><ArticleId IdType="pmc">PMC7691906</ArticleId><ArticleId IdType="pubmed">33282193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front Physiol. 2020;11:605908. doi: 10.3389/fphys.2020.605908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605908</ArticleId><ArticleId IdType="pmc">PMC7844210</ArticleId><ArticleId IdType="pubmed">33519510</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado F, Morales D, D&#xed;az-Papapietro C, Vald&#xe9;s C, Fernandez C, Valls N, et al. Relationship between endothelial and angiogenesis biomarkers envisage mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front Med. 2022;9:826218. doi: 10.3389/fmed.2022.826218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.826218</ArticleId><ArticleId IdType="pmc">PMC8966493</ArticleId><ArticleId IdType="pubmed">35372407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes-Paciencia S, Saint-Germain E, Rowell MC, Ruiz AF, Kalegari P, Ferbeyre G. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15&#x2013;22. doi: 10.1016/j.cyto.2019.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.01.013</ArticleId><ArticleId IdType="pubmed">30776684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599:283&#x2013;9. doi: 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med. 2021;13:eabj7790. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Patra T, Vijayamahantesh, Ray R. SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells. J Virol. 2021;95:e0079421. doi: 10.1128/JVI.00794-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00794-21</ArticleId><ArticleId IdType="pmc">PMC8354225</ArticleId><ArticleId IdType="pubmed">34160250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250&#x2013;6. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Wu X, Zheng X, Luo S, Xu S, Weng J. Targeting inflammation and cytokine storm in COVID-19. Pharmacol Res. 2020;159:105051. doi: 10.1016/j.phrs.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105051</ArticleId><ArticleId IdType="pmc">PMC7320704</ArticleId><ArticleId IdType="pubmed">32603772</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Zuo Q, Li Y, Oduro PK, Tan F, Wang Y, et al. A vicious cycle: in severe and critically Ill COVID-19 patients. Front Immunol. 2022;13:930673. doi: 10.3389/fimmu.2022.930673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.930673</ArticleId><ArticleId IdType="pmc">PMC9240200</ArticleId><ArticleId IdType="pubmed">35784318</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa TJ, Potje SR, Fraga-Silva TFC, da Silva-Neto JA, Barros PR, Rodrigues D, et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vasc Pharmacol. 2021;142:106946. doi: 10.1016/j.vph.2021.106946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106946</ArticleId><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol. 2021;6:eabh2259. doi: 10.1126/sciimmunol.abh2259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh2259</ArticleId><ArticleId IdType="pmc">PMC8158979</ArticleId><ArticleId IdType="pubmed">34446527</ArticleId></ArticleIdList></Reference><Reference><Citation>Georg P, Astaburuaga-Garc&#xed;a R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2021;185:493&#x2013;12. doi: 10.1016/j.cell.2021.12.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.040</ArticleId><ArticleId IdType="pmc">PMC8712270</ArticleId><ArticleId IdType="pubmed">35032429</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98:314&#x2013;22. doi: 10.1016/j.kint.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8:462. doi: 10.3390/biomedicines8110462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110462</ArticleId><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets the transmembrane glycoprotein neuropilin-1 in human brain microvascular endothelial cells. Non-coding RNA. 2021;7:9. doi: 10.3390/ncrna7010009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna7010009</ArticleId><ArticleId IdType="pmc">PMC7931075</ArticleId><ArticleId IdType="pubmed">33540664</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Saredy J, Xu K, Sun Y, Saaoud F, Drummer CT, et al. Endothelial immunity trained by coronavirus infections, DAMP stimulations and regulated by anti-oxidant NRF2 may contribute to inflammations, myelopoiesis, COVID-19 cytokine storms and thromboembolism. Front Immunol. 2021;12:653110. doi: 10.3389/fimmu.2021.653110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.653110</ArticleId><ArticleId IdType="pmc">PMC8269631</ArticleId><ArticleId IdType="pubmed">34248940</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S, Sharma K, Singh PK. Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chem-Biol Interact. 2021;348:109657. doi: 10.1016/j.cbi.2021.109657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2021.109657</ArticleId><ArticleId IdType="pmc">PMC8432980</ArticleId><ArticleId IdType="pubmed">34516971</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arteriosclerosis Thrombosis Vasc Biol. 2021;41:1760&#x2013;73. doi: 10.1161/ATVBAHA.120.315595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315595</ArticleId><ArticleId IdType="pubmed">33626910</ArticleId></ArticleIdList></Reference><Reference><Citation>Osburn WO, Smith K, Yanek L, Amat-Alcaron N, Thiemann DR, Cox AL, et al. Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19. PLoS One. 2022;17:e0268296. doi: 10.1371/journal.pone.0268296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268296</ArticleId><ArticleId IdType="pmc">PMC9119480</ArticleId><ArticleId IdType="pubmed">35588115</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham GR, Kuc RE, Althage M, Greasley PJ, Ambery P, Maguire JJ, et al. Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19. J Mol Cell Cardiol. 2022;167:92&#x2013;6. doi: 10.1016/j.yjmcc.2022.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2022.03.007</ArticleId><ArticleId IdType="pmc">PMC8941861</ArticleId><ArticleId IdType="pubmed">35339512</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira RC, Minnion M, Clark AD, Dyson A, Tanus-Santos JE, Feelisch M. On the origin of nitrosylated hemoglobin in COVID-19: Endothelial NO capture or redox conversion of nitrite?: Experimental results and a cautionary note on challenges in translational research. Redox Biol. 2022;54:102362. doi: 10.1016/j.redox.2022.102362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102362</ArticleId><ArticleId IdType="pmc">PMC9181201</ArticleId><ArticleId IdType="pubmed">35709537</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Holt M, Fan M, Lam V, Yang Y, Ha T, et al. Cardiovascular dysfunction in COVID-19: association between endothelial cell injury and lactate. Front Immunol. 2022;13:868679. doi: 10.3389/fimmu.2022.868679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.868679</ArticleId><ArticleId IdType="pmc">PMC8984030</ArticleId><ArticleId IdType="pubmed">35401579</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Keskinidou C, Jahaj E, Gallos P, Dimopoulou I, Kotanidou A, et al. ICU admission levels of endothelial biomarkers as predictors of mortality in critically Ill COVID-19 patients. Cells. 2021;10:186. doi: 10.3390/cells10010186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010186</ArticleId><ArticleId IdType="pmc">PMC7832393</ArticleId><ArticleId IdType="pubmed">33477776</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira MR, Back GD, da Luz Goulart C, Domingos BC, Arena R, Borghi-Silva A. Endothelial function provides early prognostic information in patients with COVID-19: A cohort study. Respir Med. 2021;185:106469. doi: 10.1016/j.rmed.2021.106469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106469</ArticleId><ArticleId IdType="pmc">PMC8141349</ArticleId><ArticleId IdType="pubmed">34175806</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha D, Fu M, Qian Y. Vascular endothelial glycocalyx damage and potential targeted therapy in COVID-19. Cells. 2022;11:1972. doi: 10.3390/cells11121972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11121972</ArticleId><ArticleId IdType="pmc">PMC9221624</ArticleId><ArticleId IdType="pubmed">35741101</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada H, Yoshida S, Hara A, Ogura S, Tomita H. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection. Microcirculation (N. Y, N. Y: 1994) 2021;28:e12654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435519</ArticleId><ArticleId IdType="pubmed">32791568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensah SA, Cheng MJ, Homayoni H, Plouffe BD, Coury AJ, Ebong EE. Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication. PLoS One. 2017;12:e0186116. doi: 10.1371/journal.pone.0186116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186116</ArticleId><ArticleId IdType="pmc">PMC5638341</ArticleId><ArticleId IdType="pubmed">29023478</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Okada H, Tomita H, Sumi K, Kakino Y, Yasuda R, et al. Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury. Thrombosis J. 2021;19:5. doi: 10.1186/s12959-021-00258-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-021-00258-x</ArticleId><ArticleId IdType="pmc">PMC7838859</ArticleId><ArticleId IdType="pubmed">33504351</ArticleId></ArticleIdList></Reference><Reference><Citation>Drost CC, Rovas A, Osiaevi I, Rauen M, van der Vlag J, Buijsers B, et al. Heparanase is a putative mediator of endothelial glycocalyx damage in COVID-19 - A proof-of-concept study. Front Immunol. 2022;13:916512. doi: 10.3389/fimmu.2022.916512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.916512</ArticleId><ArticleId IdType="pmc">PMC9226442</ArticleId><ArticleId IdType="pubmed">35757776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Li L, Chen Y, Ma J, Yang Y, Aodeng S, et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med (Camb, Mass) 2021;27:151. doi: 10.1186/s10020-021-00412-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00412-1</ArticleId><ArticleId IdType="pmc">PMC8640509</ArticleId><ArticleId IdType="pubmed">34861818</ArticleId></ArticleIdList></Reference><Reference><Citation>Khider L, Gendron N, Goudot G, Chocron R, Hauw-Berlemont C, Cheng C, et al. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thrombosis Haemost. 2020;18:2391&#x2013;9. doi: 10.1111/jth.14968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14968</ArticleId><ArticleId IdType="pmc">PMC7323356</ArticleId><ArticleId IdType="pubmed">32558198</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C, Burtey S, Sabatier F, Cauchois R, Lano G, Abdili E, et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID -19. J Infect Dis. 2020;222:1789&#x2013;93. doi: 10.1093/infdis/jiaa528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa528</ArticleId><ArticleId IdType="pmc">PMC7454721</ArticleId><ArticleId IdType="pubmed">32812049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KCH, Sewa DW, Phua GC. Potential role of statins in COVID-19. Int J Infect Dis. 2020;96:615&#x2013;7. doi: 10.1016/j.ijid.2020.05.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.115</ArticleId><ArticleId IdType="pmc">PMC7265877</ArticleId><ArticleId IdType="pubmed">32502659</ArticleId></ArticleIdList></Reference><Reference><Citation>Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective effects of statins administration in European and North American patients infected with COVID-19: a meta-analysis. Semin Thrombosis Hemost. 2021;47:392&#x2013;9. doi: 10.1055/s-0040-1722307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1722307</ArticleId><ArticleId IdType="pubmed">33482680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32:176&#x2013;87. doi: 10.1016/j.cmet.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7311917</ArticleId><ArticleId IdType="pubmed">32592657</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, et al. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther. 2021;6:266. doi: 10.1038/s41392-021-00690-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00690-5</ArticleId><ArticleId IdType="pmc">PMC8273371</ArticleId><ArticleId IdType="pubmed">34253708</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlos A, Niedzielski M, Gorzelak-Pabi&#x15b; P, Broncel M, Wo&#x17a;niak E. COVID-19: direct and indirect mechanisms of statins. Int J Mol Sci. 2021;22:4177. doi: 10.3390/ijms22084177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084177</ArticleId><ArticleId IdType="pmc">PMC8073792</ArticleId><ArticleId IdType="pubmed">33920709</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 diabetes mellitus and COVID-19: a narrative review. Front Endocrinol. 2021;12:609470. doi: 10.3389/fendo.2021.609470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.609470</ArticleId><ArticleId IdType="pmc">PMC8044543</ArticleId><ArticleId IdType="pubmed">33868163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Zhou Y, Ling P, Feng X, Luo S, Zheng X, et al. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics. 2021;11:9376&#x2013;96. doi: 10.7150/thno.64706.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.64706</ArticleId><ArticleId IdType="pmc">PMC8490502</ArticleId><ArticleId IdType="pubmed">34646376</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel SM, Varghese E, B&#xfc;sselberg D. Therapeutic potential of metformin in COVID-19: reasoning for its protective role. Trends Microbiol. 2021;29:894&#x2013;907. doi: 10.1016/j.tim.2021.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.004</ArticleId><ArticleId IdType="pmc">PMC7955932</ArticleId><ArticleId IdType="pubmed">33785249</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T, Ma S, Sun C, Zhang H, Qu G, Chen Y, et al. The association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis. Arch Med Res. 2021;53:186&#x2013;95. doi: 10.1016/j.arcmed.2021.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8349690</ArticleId><ArticleId IdType="pubmed">34412904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Liu YM, Li H, Zhang X, Lei F, Qin JJ, et al. Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;32:537&#x2013;47. doi: 10.1016/j.cmet.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7439986</ArticleId><ArticleId IdType="pubmed">32861268</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, et al. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics. 2021;11:4502&#x2013;15. doi: 10.7150/thno.54498.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.54498</ArticleId><ArticleId IdType="pmc">PMC7977463</ArticleId><ArticleId IdType="pubmed">33754074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauersachs J, de Boer RA, Lindenfeld J, Bozkurt B. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J. 2022;43:367&#x2013;76. doi: 10.1093/eurheartj/ehab887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab887</ArticleId><ArticleId IdType="pmc">PMC9383181</ArticleId><ArticleId IdType="pubmed">34974611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, &#xc1;inle FN, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021;375:n2400. doi: 10.1136/bmj.n2400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2400</ArticleId><ArticleId IdType="pmc">PMC8515466</ArticleId><ArticleId IdType="pubmed">34649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care (Lond, Engl) 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanski J, Kazmouz SG, Li S, Stansfield B, Salem TT, Perez-Miller S, et al. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem Cell Rep. 2021;16:2459&#x2013;72. doi: 10.1016/j.stemcr.2021.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.08.018</ArticleId><ArticleId IdType="pmc">PMC8407952</ArticleId><ArticleId IdType="pubmed">34525378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized With COVID-19. Circ Res. 2020;126:1671&#x2013;81. doi: 10.1161/CIRCRESAHA.120.317134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317134</ArticleId><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetlow S, Segiet-Swiecicka A, O&#x2019;Sullivan R, O&#x2019;Halloran S, Kalb K, Brathwaite-Shirley C, et al. ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19. J Intern Med. 2021;289:688&#x2013;99. doi: 10.1111/joim.13202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13202</ArticleId><ArticleId IdType="pmc">PMC7753609</ArticleId><ArticleId IdType="pubmed">33210357</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WY, Kweon OJ, Cha MJ, Baek MS, Choi SH. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot stud. PLoS One. 2021;16:e0254167. doi: 10.1371/journal.pone.0254167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254167</ArticleId><ArticleId IdType="pmc">PMC8253399</ArticleId><ArticleId IdType="pubmed">34214123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med. 2021;53:1116&#x2013;23. doi: 10.1038/s12276-021-00649-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00649-0</ArticleId><ArticleId IdType="pmc">PMC8273570</ArticleId><ArticleId IdType="pubmed">34253862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci USA. 2020;117:22351&#x2013;6. doi: 10.1073/pnas.2010229117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010229117</ArticleId><ArticleId IdType="pmc">PMC7486751</ArticleId><ArticleId IdType="pubmed">32826331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Pavlidis G, Katsimbri P, Lambadiari V, Parissis J, Andreadou I, et al. Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19. Food Chem Toxicol. 2020;145:111694. doi: 10.1016/j.fct.2020.111694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2020.111694</ArticleId><ArticleId IdType="pmc">PMC7434461</ArticleId><ArticleId IdType="pubmed">32822775</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA mitigates SARS-CoV-2-induced inflammatory lung vascular leakage and mortality in humanized K18-hACE-2 mice. Arterioscler Thrombosis Vasc Biol. 2021;41:2773&#x2013;85. doi: 10.1161/ATVBAHA.121.316925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.121.316925</ArticleId><ArticleId IdType="pmc">PMC8545251</ArticleId><ArticleId IdType="pubmed">34496633</ArticleId></ArticleIdList></Reference><Reference><Citation>Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, et al. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;2:e393&#x2013;e400. doi: 10.1016/S2665-9913(20)30164-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30164-8</ArticleId><ArticleId IdType="pmc">PMC7259909</ArticleId><ArticleId IdType="pubmed">32835245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P, et al. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021;3:e690&#x2013;e7. doi: 10.1016/S2665-9913(21)00216-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00216-2</ArticleId><ArticleId IdType="pmc">PMC8352496</ArticleId><ArticleId IdType="pubmed">34396156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schattner A. Colchicine-new horizons for an ancient drug. Eur J Intern Med. 2022;96:34&#x2013;41. doi: 10.1016/j.ejim.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.10.002</ArticleId><ArticleId IdType="pubmed">34657777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang FS, He QZ, Qin CH, Little PJ, Weng JP, Xu SW. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2021;43:2173&#x2013;90. doi: 10.1038/s41401-021-00835-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-021-00835-w</ArticleId><ArticleId IdType="pmc">PMC8767044</ArticleId><ArticleId IdType="pubmed">35046517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402. doi: 10.1038/s41392-021-00791-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00791-1</ArticleId><ArticleId IdType="pmc">PMC8617206</ArticleId><ArticleId IdType="pubmed">34824210</ArticleId></ArticleIdList></Reference><Reference><Citation>Satarker S, Tom AA, Shaji RA, Alosious A, Luvis M, Nampoothiri M. JAK-STAT pathway inhibition and their implications in COVID-19 therapy. Postgrad Med. 2021;133:489&#x2013;507. doi: 10.1080/00325481.2020.1855921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2020.1855921</ArticleId><ArticleId IdType="pmc">PMC7784782</ArticleId><ArticleId IdType="pubmed">33245005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021;40:101125. doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskotsky T, Maric I, Tang A, Oskotsky B, Wong RJ, Aghaeepour N, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open. 2021;4:e2133090. doi: 10.1001/jamanetworkopen.2021.33090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.33090</ArticleId><ArticleId IdType="pmc">PMC8593759</ArticleId><ArticleId IdType="pubmed">34779847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324:2292&#x2013;300. doi: 10.1001/jama.2020.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22760</ArticleId><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G, Dos Santos Moreira-Silva EA, Silva DCM, Thabane L, Milagres AC, Ferreira TS, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022;10:e42&#x2013;e51. doi: 10.1016/S2214-109X(21)00448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00448-4</ArticleId><ArticleId IdType="pmc">PMC8550952</ArticleId><ArticleId IdType="pubmed">34717820</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos KI, Sutheesophon W, Aw TC. Anti-SARS-CoV-2 action of fluvoxamine may be mediated by endothelial nitric oxide synthase. Pharmacopsychiatry. 2022;55:57. doi: 10.1055/a-1641-0357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1641-0357</ArticleId><ArticleId IdType="pubmed">34555857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemil&#xe4; H, de Man AME. Vitamin C and COVID-19. Front Med. 2020;7:559811. doi: 10.3389/fmed.2020.559811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.559811</ArticleId><ArticleId IdType="pmc">PMC7848027</ArticleId><ArticleId IdType="pubmed">33537320</ArticleId></ArticleIdList></Reference><Reference><Citation>May CN, Bellomo R, Lankadeva YR. Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19. Br J Pharmacol. 2021;178:3864&#x2013;8. doi: 10.1111/bph.15579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15579</ArticleId><ArticleId IdType="pmc">PMC8239596</ArticleId><ArticleId IdType="pubmed">34061355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasa-Irriguible TM, Bielsa-Berrocal L. COVID-19: Up to 82% critically ill patients had low vitamin C values. Nutr J. 2021;20:66. doi: 10.1186/s12937-021-00727-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-021-00727-z</ArticleId><ArticleId IdType="pmc">PMC8269403</ArticleId><ArticleId IdType="pubmed">34243781</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia G, Qin B, Ma C, Zhu Y, Zheng Q. High-dose vitamin C ameliorates cardiac injury in COVID-19 pandemic: a retrospective cohort study. Aging. 2021;13:20906&#x2013;14. doi: 10.18632/aging.203503.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203503</ArticleId><ArticleId IdType="pmc">PMC8457586</ArticleId><ArticleId IdType="pubmed">34499050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess AL, Halalau A, Dokter JJ, Paydawy TS, Karabon P, Bastani A, et al. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Intern Emerg Med. 2022: 1-10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8961256</ArticleId><ArticleId IdType="pubmed">35349005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowmik KK, Barek MA, Aziz MA, Islam MS. Impact of high-dose vitamin C on the mortality, severity, and duration of hospital stay in COVID-19 patients: a meta-analysis. Health Sci Rep. 2022;5:e762. doi: 10.1002/hsr2.762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.762</ArticleId><ArticleId IdType="pmc">PMC9358542</ArticleId><ArticleId IdType="pubmed">35949675</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R, Xiang X, Chen W, Yang Z, Hu W, Qu H, et al. Efficacy of diammonium glycyrrhizinate combined with vitamin C for treating hospitalized COVID-19 patients: a retrospective, observational study. QJM. 2022;115:77&#x2013;83. doi: 10.1093/qjmed/hcab184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab184</ArticleId><ArticleId IdType="pmc">PMC8420637</ArticleId><ArticleId IdType="pubmed">34314507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zheng C, Chen T, Huang D, Pan Y, Chen S. Relationship between plasma vitamin C and COVID-19 susceptibility and severity: a two-sample mendelian randomization study. Front Med. 2022;9:844228. doi: 10.3389/fmed.2022.844228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.844228</ArticleId><ArticleId IdType="pmc">PMC8959865</ArticleId><ArticleId IdType="pubmed">35355592</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani GP, Macchi M, Guz-Mark A. Vitamin C in the treatment of COVID-19. Nutrients. 2021;13:1172. doi: 10.3390/nu13041172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041172</ArticleId><ArticleId IdType="pmc">PMC8065688</ArticleId><ArticleId IdType="pubmed">33916257</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N, Li S High-quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID-19. Phytother Res. 2022, 10.1002/ptr.7574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538057</ArticleId><ArticleId IdType="pubmed">35915552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X, Jin D, Jiang L, Zhang Y, Zhang Y, An X, et al. Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review. Chin Med. 2022;17:30. doi: 10.1186/s13020-022-00587-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-022-00587-7</ArticleId><ArticleId IdType="pmc">PMC8883015</ArticleId><ArticleId IdType="pubmed">35227280</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing D, Liu Z. Effectiveness and safety of traditional chinese medicine in treating COVID-19: clinical evidence from China. Aging Dis. 2021;12:1850&#x2013;6. doi: 10.14336/AD.2021.0906.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0906</ArticleId><ArticleId IdType="pmc">PMC8612612</ArticleId><ArticleId IdType="pubmed">34881072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Wen Z, Hu X, Tang W, Wang H, Zhou L, et al. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med. 2021;15:704&#x2013;17. doi: 10.1007/s11684-021-0853-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-021-0853-6</ArticleId><ArticleId IdType="pmc">PMC8079840</ArticleId><ArticleId IdType="pubmed">33909260</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Zhu H, Liu Y, Lu Y, Sun M, Zhang Y, et al. Role of traditional chinese medicine in treating severe or critical covid-19: a systematic review of randomized controlled trials and observational studies. Front Pharmacol. 2022;13:926189. doi: 10.3389/fphar.2022.926189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.926189</ArticleId><ArticleId IdType="pmc">PMC9336221</ArticleId><ArticleId IdType="pubmed">35910363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, M&#xfc;ller-Fielitz H, Schuster R, Zille M, M&#xfc;ller K, et al. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021;24:1522&#x2013;33. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: Insights From TUN-EndCOV study. Front Cardiovasc Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, et al. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021;12:814. doi: 10.1038/s41467-021-21085-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21085-8</ArticleId><ArticleId IdType="pmc">PMC7864918</ArticleId><ArticleId IdType="pubmed">33547300</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakas M, Jarczak D, Becker M, Roedl K, Addo MM, Hein F, et al. Targeting endothelial dysfunction in eight extreme-critically ill patients with COVID-19 using the anti-adrenomedullin antibody adrecizumab (HAM8101) Biomolecules. 2020;10:1171. doi: 10.3390/biom10081171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10081171</ArticleId><ArticleId IdType="pmc">PMC7465983</ArticleId><ArticleId IdType="pubmed">32796765</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020;11:707&#x2013;22. doi: 10.1007/s13238-020-00738-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00738-2</ArticleId><ArticleId IdType="pmc">PMC7282699</ArticleId><ArticleId IdType="pubmed">32519302</ArticleId></ArticleIdList></Reference><Reference><Citation>Breithaupt-Faloppa AC, Correia CJ, Prado CM, Stilhano RS, Ureshino RP, Moreira LFP. 17&#x3b2;-Estradiol, a potential ally to alleviate SARS-CoV-2 infection. Clin (Sao Paulo, Braz) 2020;75:e1980. doi: 10.6061/clinics/2020/e1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2020/e1980</ArticleId><ArticleId IdType="pmc">PMC7233687</ArticleId><ArticleId IdType="pubmed">32490931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecon E, Fernandois D, Renault N, Coelho CFF, Wenzel J, Bedart C, et al. Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels. Cell Mol Life Sci. 2022;79:361. doi: 10.1007/s00018-022-04390-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04390-3</ArticleId><ArticleId IdType="pmc">PMC9191404</ArticleId><ArticleId IdType="pubmed">35697820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang W, Jiang J, Su L, Shu T, Liu H, Lai S, et al. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med. 2021;163:153&#x2013;62. doi: 10.1016/j.freeradbiomed.2020.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.12.008</ArticleId><ArticleId IdType="pmc">PMC7754882</ArticleId><ArticleId IdType="pubmed">33347987</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Jiang M, Yang J. Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int J Infect Dis. 2021;107:232&#x2013;3. doi: 10.1016/j.ijid.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.05.001</ArticleId><ArticleId IdType="pmc">PMC8119437</ArticleId><ArticleId IdType="pubmed">33965598</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller R, Rink G, Uzun G, Bakchoul T, Wuchter P, Kl&#xfc;ter H, et al. Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors. Thrombosis Res. 2022;216:120&#x2013;4. doi: 10.1016/j.thromres.2022.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.06.014</ArticleId><ArticleId IdType="pmc">PMC9252887</ArticleId><ArticleId IdType="pubmed">35810548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansiroglu AK, Seymen H, Sincer I, Gunes Y. Evaluation of endothelial dysfunction in COVID-19 with flow-mediated dilatation. Arq Bras Cardiol. 2022;119:319&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363072</ArticleId><ArticleId IdType="pubmed">35674570</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R, Freishtat N, Hill E, Rehman M, Freishtat R, Koutroulis I. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int J Obes (2005) 2021;45:1163&#x2013;9. doi: 10.1038/s41366-021-00804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00804-7</ArticleId><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>